Skip to search formSkip to main contentSkip to account menu

Anti-CEA Antibody

Known as: Anti-Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Antibody, CEA Antibody, Anti-CEACAM5 Antibody 
Any antibody against the tumor associated antigen carcinoembryonic antigen (CEA; CEACAM5), with potential antineoplastic activity. The CEA antigen is… 
National Institutes of Health

Related topics

Related topics

2 relations
Immune System Processesantigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas.
Solid tumors have a heterogeneous pathophysiology, which directly affects antibody-targeted therapies. Here, we consider the… 
2007
2007
Combining Radioimmunotherapy with Antihypoxia Therapy 2-Deoxy-d-Glucose Results in Reduction of Therapeutic Efficacy
Purpose: The efficacy of solid tumor radioimmunotherapy is reduced by heterogeneous tumor distribution of the radionuclide, with… 
Highly Cited
2003
Highly Cited
2003
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
PURPOSE With increasing interest in pretargeting procedures for improving the delivery of radionuclides for cancer imaging and… 
2002
2002
Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study
Antibody engineering has made it possible to design antibodies with optimal characteristics for delivery of radionuclides for… 
2002
2002
Synergy between vascular targeting agents and antibody-directed therapy.
1995
1995
Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
1990
1990
Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
The pharmacokinetics of the C110 anti-carcinoembryonic antigen antibody radiolabeled with 111In via a novel benzylisothiocyanate… 
1988
1988
Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts.
The injection of an antiantibody (second antibody, SA) can enhance the clearance rate of a radiolabeled antitumor antibody… 
1987
1987
Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025.
The present study was undertaken to determine whether an anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAB), labeled… 
1985
1985
Biochemical and Immunohistochemical Studies on the Scirrhous Carcinoma of Human Stomach a
Tumor mass of the stomach from patients with scirrhous carcinoma was analyzed biochemically and immunohistochemically to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)